Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
2007
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
2004
Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
2007
Primary Prevention of Ischemic Stroke
2006
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial
2008
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair
2005
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Effects of low‐dose warfarin and aspirin versus no treatment on stroke in a medium‐risk patient population with atrial fibrillation
2003
Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial☆
2003
Amiodarone to Prevent Recurrence of Atrial Fibrillation
2000
Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation
2005
Left Atrial Appendage Occlusion: Lessons Learned From Surgical and Transcatheter Experiences
2011
Suppression of paroxysmal atrial tachyarrhythmias ? results of the SOPAT trial
2004
Evidence-Based Management of Anticoagulant Therapy
2012
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
2010
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community
2003
Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation
2003
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
2006
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
2012
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Risk Factors for Ischaemic Stroke
2008
The Failing Heart — An Engine Out of Fuel
2007 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Trends in case-fatality in 22 968 patients admitted for the first time with atrial fibrillation in Scotland, 1986–1995
2002
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
2008
Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation
2004
Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
2008 Standout
Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation
2012
Perioperative Management of Antithrombotic Therapy
2012 Standout
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
1999
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Oral Anticoagulant Therapy
2012 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
2008
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study
2007
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
2003
Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines
2007
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
2002
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Effects of Prior Aspirin and Anti-Ischemic Therapy on Outcome of Patients With Unstable Angina 11This study was supported by Biogen, Inc., Cambridge, Massachusetts. Manuscript received July 28, 1997; revised manuscript received and accepted December 1, 1997.
1998
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians
2002
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
2012
Guidelines for the Primary Prevention of Stroke
2010
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Thyroid Hormone and the Cardiovascular System
2001 Standout
Randomisation to protect against selection bias in healthcare trials
2007
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation
1993
A Study of the Safety of Continued Anticoagulation for Cataract Surgery Patients
2006
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
2003
Association of Left Atrial Fibrosis Detected by Delayed-Enhancement Magnetic Resonance Imaging and the Risk of Stroke in Patients With Atrial Fibrillation
2011
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?
1998
Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
2011
Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
2013
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Double Data Entry: What Value, What Price?
1998
Mixed Comparison of Stroke Prevention Treatments in Individuals With Nonrheumatic Atrial Fibrillation
2006
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
A comparison study: paper-based versus web-based data collection and management
2005
Platelet Activation and Atherothrombosis
2007 Standout
Management of Patients With Atrial Fibrillation
1996
Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)
2007
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
2005
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation
2001
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study
2006
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe
2007
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
2010
Antithrombotic Therapy in Atrial Fibrillation
2004
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
The Perioperative Management of Antithrombotic Therapy
2008
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
2006
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Improving survival for patients with advanced heart failure: A study of 737 consecutive patients
1995
The management of atrial fibrillation
1996
Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure
1990
Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation
2000
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials
2006
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
2012
Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)
2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
2002
Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation
2005
Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease
2011
A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation
2004
A longitudinal population‐based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990–1999
2006
Atrial Fibrillation: A Risk Factor for Increased Mortality – An AVID Registry Analysis
2001
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation
1996
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
2000
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation
2002
Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke
2005
Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation
2006
Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
2005
Oral Anticoagulation and Hemorrhagic Complications in an Elderly Population With Atrial Fibrillation
2001
Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter
2003
Atrial fibrillation and stroke prevention
2007
Antithrombotic Therapy in Atrial Fibrillation
2001
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
2006
Is double data entry necessary? The CHART trials
1994
Heart failure after myocardial infarction: a review
2002
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
2004
Antithrombotic Therapy for Atrial Fibrillation
2012
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation
1999
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Antithrombotic Therapy in Atrial Fibrillation
2008
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Translating the Results of Randomized Trials into Clinical Practice
2006
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
[Guidelines for the management of patients with atrial fibrillation. Executive summary].
2006
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Discussion
1999
Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies
2000
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
2008
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
2005
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
2001 Standout
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.
2007
Selecting Patients With Atrial Fibrillation for Anticoagulation
2004
Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation
2004
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
2002
Potential New Risk Factors for Ischemic Stroke
2006
Low-Dose Aspirin for Prevention of Stroke in Low-Risk Patients With Atrial Fibrillation
2005
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
2003
Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial
2001
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation
2007
Moving the Tipping Point
2010
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2019
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
2005
Factors that limit the quality, number and progress of randomised controlled trials.
1999
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
2005
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation
2008
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
2010
Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
2012
Clinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation
2000
Randomisation to protect against selection bias in healthcare trials
2011
Current Trial-Associated Outcomes With Warfarin in Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation
2012
Postmenopausal Hormone Therapy and Risk of Stroke
2001
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks
2007
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
2005
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
2006
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
2005
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
2008
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
1999
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
2004
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?
2003
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter
2000
Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force
2002
A comparison of error detection rates between the reading aloud method and the double data entry method
2003
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation
2000
The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
2007
Works of Ruth McBride being referenced
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)
1989
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study
1999
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
1992
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
1999
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
1999
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.
2000
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation
1999
Prospective Comparison of Patient Characteristics and Outcome of Non-prior Aspirin Users versus Aspirin Users with Unstable Angina or Non-Q-Wave Myocardial Infarction Treated with Combination Antithrombotic Therapy
1997
Stroke Prevention in Atrial Fibrillation II Study
1994
Single vs. Double data entry in CAST
1992
Lessons from the Stroke Prevention in Atrial Fibrillation Trials
2003